{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Morton Grove",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88629",
      "recalling_firm": "Morton Grove Pharmaceuticals, Inc.",
      "address_1": "6451 Main St",
      "address_2": "",
      "postal_code": "60053-2633",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide USA and China",
      "recall_number": "D-0816-2021",
      "product_description": "Valproic Acid Oral Solution USP,  (250 mg/5 mL),  1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-621-16",
      "product_quantity": "38,748 bottles",
      "reason_for_recall": "CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.",
      "recall_initiation_date": "20210903",
      "center_classification_date": "20210920",
      "report_date": "20210929",
      "code_info": "Lot #: UV1159",
      "more_code_info": ""
    }
  ]
}